Funding · Healthcare & Life Sciences
CuraPod raises ₹20 crore pre-Series A round
By Startup Enthusiast ·
- Date
- Company
- CURAPOD
- What it does
- Wearable pain management devices
- Kind
- Funding
- Amount
- ₹20 Cr
- Stage
- pre-Series A
- Founded
- 2022
What they do
CuraPod makes wearable medical devices for musculoskeletal pain relief
What happened
It raised ₹20 Cr ($2.2 Mn) from V3 Ventures, 3i Partners and Ideaspring Capital
Why it matters
The company targets 5X revenue growth and plans to enter Europe
The details
- CuraPod raised ₹20 Cr ($2.2 Mn) in a pre-Series A round.
- The round was led by V3 Ventures, 3i Partners and Ideaspring Capital.
- The funds will be used for product enhancements, marketplace sales and marketing.
- CuraPod also plans to expand into gym, physio and sports medicine partnerships.
- It will scale manufacturing and strengthen go-to-market operations.
- The company is preparing to enter the Europe market.
- CuraPod aims to build a broader portfolio of light therapy-based health solutions.
The bigger picture
- Healthtech funding and deal volumes have declined in India recently.
- The Indian healthtech market is expected to cross $37 Bn by 2030.
- The sector is shifting from episodic care to prevention, with startups like Ultrahuman and Noise selling smart wearables.
- Eternal cofounder Deepinder Goyal is exploring a wearable device company called 'Temple' for brain monitoring.
About the business
- CuraPod manufactures a wearable medical device for musculoskeletal pain management.
- The device is engineered and manufactured in India.
- It uses medical-grade photobiomodulation technology (red light wavelengths).
- The device works at the cellular level to reduce inflammation, improve circulation and support tissue repair.
- Pain relief requires 30-60 minutes of daily use.
- The device is FDA-registered and supports over 30 musculoskeletal conditions.
- Conditions include back pain, neck pain, knee pain, joint disorders, muscle stiffness, sports injuries and chronic injuries.
What happens next
- CuraPod will enhance its product and app.
- It will expand marketplace sales and marketing.
- It will partner with gyms, physiotherapists and sports medicine professionals.
- It will scale manufacturing and go-to-market operations.
- It is preparing to enter the Europe market.
- It plans to build a broader portfolio of light therapy-based health solutions.
The deal
- Type
- equity
Investors
- V3 Ventures (lead)
- 3i Partners (lead)
- Ideaspring Capital (lead)
Founders
- Sri Velliyur, cofounder & CEO
- Surya Prakash Maguluri, cofounder
About CURAPOD
- Product
- management device maker
- Customers
- Individuals with musculoskeletal pain, and also gyms, physiotherapy centres, and sports medicine networks as partners.
- How it makes money
- Sells wearable pain relief devices directly to consumers and through partnerships with gyms and physiotherapy networks.
- What sets it apart
- India's first CDSCO-approved personalized drug-free pain relief wearable; FDA-registered; engineered and manufactured in India.
Other articles talking about it
Same day
- BotGauge AI raises $2 million seed funding10 February 2026 · Funding · $2 million
- Slurrp Farm raises ₹30 crore in extended Series C10 February 2026 · Funding · ₹30 crore
- Supertails raises $30 Mn Series C10 February 2026 · Funding · $30 Mn (₹271.7 Cr)
- Goat Life raises ₹2 crore from sharks on Shark Tank10 February 2026 · Funding · ₹2 crore
- Wakefit doubles profit, names new CFO10 February 2026 · Results
- Ather Energy partners with Ecofy Finance for green financing10 February 2026 · Partnership · ₹100 crore